CDC logo
Safer Healthier People
CDC Home CDC Search CDC Health Topics A-Z
NIOSH - National Institute for Occupational Safety and Health

Skip navigation links Search NIOSH  |  NIOSH Home  |  NIOSH Topics  |  Site Index  |  Databases and Information Resources  |  NIOSH Products  |  Contact Us

Search for NIOSH Publications: NIOSHTIC-2

NIOSHTIC-2 Search Results

      Advanced Search  |  Help  |  About  |  Feedback 
Terms: 20025318
1 - 1 of 1 Bibliographic entries
All record(s) shown.
Save All   |   Save Page
View Saved    |    Download
Select check boxes to automatically save entries, or use 'save all' or 'save page' links above.

The latex allergen Hev b 5 is an antigen with repetitive murine B-cell epitopes.
Authors
Beezhold-DH; Hickey-VL; Sutherland-MF; O'Hehir-RE
Source
Int Arch Allergy Immunol 2004 Aug; 134(4):334-340
Link
http://dx.doi.org/10.1159/000079537 
NIOSHTIC No.
20025318 
Abstract
Hev b 5 is a potent latex allergen. In this study, we characterize the linear B-cell epitopes for three monoclonal antibodies (mAbs) to Hev b 5. The mAbs included 2 IgG1 (6A10, 3G3) and 1 IgG2b (6F6) isotypes. We used SPOTscan analysis with overlapping octapeptides to identify the binding regions for the antibodies and then methionine substitution analysis to further define the critical amino acids (aa) in each epitope. Site-directed mutagenesis was used to selectively eliminate the IgG binding for each epitope and single and multiple mutations were expressed as recombinant GST fusion proteins. Antibody recognition of the mutant proteins was determined by inhibition ELISA. All three mAbs recognized the same aa sequence by SPOTs analysis with slight variations, and this epitope was repeated 3 times in the Hev b 5 sequence; APETEK (63-68), PAEGEK (120-125), and PAEEEK (126-131). Sequential methionine substitution by SPOTsalogue identified K68, E122, and K131 as critical aa in each epitope to change by site-directed mutagenesis. Inhibition ELISA with the mutant proteins indicated that epitope 126-131 was the dominant epitope, but mutation of epitope 120-125 was also required to eliminate mAb reactivity to Hev b 5. The antibodies did not appear to recognize the epitope 63-68 in the recombinant fusion protein. We identified an immunodominant B-cell epitope in Hev b 5 that is repeated 3 times within the sequence, making Hev b 5 multivalent. Well-characterized monoclonals recognizing repeated epitopes would be a good choice for immunodetection of Hev b 5 in glove extracts where individual epitopes could get altered by the manufacturing process.
Keywords
Allergens; Antigens; Mutagenesis; Amino-acids; Proteins; Bioassays; Antibody-response
Page 1 of 1
All record(s) shown.

File Formats Help:

Adobe PDF file
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?double arrows.